Darwiche G, Almer LO, Bjorgell O, et al
Because retatrutide does not yet hold a UK marketing authorisation, it is not subject to the same post-marketing pharmacovigilance requirements as licensed medicines
Oxford: Wiley-Blackwell
In fact, it's so hard to measure that protein researchers out there, please don't get too mad at me saying this because I was one of you, but we just kind of do this and we go la, la, la, and we just kind of follow muscle protein synthesis because degradation is so hard to measure because if you're measuring synthesis, you're using an isotopic label and you're just, you're looking at incorporation into the tissue versus the precursor pool
Image: Galina Zhigalova/Getty Images About the Author Maureen Salamon, Executive Editor, Harvard Women's Health Watch About the Reviewer Meghan Salamon, MS, RDN, LDN, CPT, Contributor Disclaimer: As a service to our readers, Harvard Health Publishing provides access to our library of archived content
